3/7
08:13 am
sln
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Low
Report
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
3/5
09:07 am
sln
Rating for SLN
Medium
Report
Rating for SLN
3/5
09:07 am
sln
Rating for SLN
Medium
Report
Rating for SLN
3/4
12:56 pm
sln
Rating for SLN
Low
Report
Rating for SLN
3/4
12:56 pm
sln
Rating for SLN
Low
Report
Rating for SLN
3/4
09:32 am
sln
Rating for SLN
Medium
Report
Rating for SLN
3/4
09:32 am
sln
Rating for SLN
Medium
Report
Rating for SLN
3/4
09:32 am
sln
Rating for SLN
Medium
Report
Rating for SLN
2/11
04:23 am
sln
Rating for SLN
High
Report
Rating for SLN
2/11
04:23 am
sln
Rating for SLN
High
Report
Rating for SLN
2/11
04:23 am
sln
Rating for SLN
High
Report
Rating for SLN
2/10
04:14 pm
sln
Silence Therapeutics initiated with a Sell at Goldman Sachs
High
Report
Silence Therapeutics initiated with a Sell at Goldman Sachs
2/10
04:14 pm
sln
Silence Therapeutics initiated with a Sell at Goldman Sachs
High
Report
Silence Therapeutics initiated with a Sell at Goldman Sachs
2/10
04:14 pm
sln
Silence Therapeutics initiated with a Sell at Goldman Sachs
High
Report
Silence Therapeutics initiated with a Sell at Goldman Sachs
1/29
01:21 pm
sln
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Report
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.